X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (114) 114
science & technology (114) 114
humans (100) 100
cardiovascular system & cardiology (98) 98
cardiac & cardiovascular systems (95) 95
cardiovascular (76) 76
acc/aha clinical practice guidelines (73) 73
abridged index medicus (64) 64
internal medicine (63) 63
cardiology (60) 60
cardiovascular disease (51) 51
task forces (51) 51
heart failure (43) 43
cardiology and cardiovascular medicine (42) 42
united states (41) 41
american heart association (40) 40
heart (40) 40
care and treatment (36) 36
clinical medicine (35) 35
cardiology - standards (31) 31
myocardial infarction (31) 31
risk assessment (31) 31
heart attacks (29) 29
hypertension (29) 29
practice guidelines (29) 29
writing (29) 29
acc/aha clinical practice guideline (28) 28
risk factors (28) 28
acc/aha guidelines (27) 27
practice guidelines as topic (27) 27
blood pressure (26) 26
female (26) 26
adult (25) 25
male (25) 25
athletes (24) 24
congenital heart disease (23) 23
cardiomyopathy (22) 22
cardiovascular diseases (22) 22
catheter ablation (22) 22
guidelines (22) 22
patients (21) 21
adults (20) 20
atrial fibrillation (20) 20
mortality (20) 20
cardiac arrhythmia (19) 19
coronary artery disease (19) 19
focused update (19) 19
hospitals (19) 19
acc/aha performance measures (18) 18
cardiac patients (18) 18
colleges & universities (18) 18
heart beat (18) 18
acute coronary syndrome (17) 17
aged (17) 17
cardiac resynchronization therapy (17) 17
cholesterol (17) 17
disease management (17) 17
drug therapy (17) 17
primary prevention (17) 17
surgery (17) 17
atrial flutter (16) 16
electrocardiography (16) 16
implantable cardioverter-defibrillator (16) 16
sudden cardiac death (16) 16
arrhythmia (15) 15
heart diseases (15) 15
medicine (15) 15
middle aged (15) 15
practice guidelines as topic - standards (15) 15
peripheral vascular disease (14) 14
sarcoidosis (14) 14
studies (14) 14
syncope (14) 14
acc/aha scientific statements (13) 13
beta blockers (13) 13
cardiology - methods (13) 13
clinical trials (13) 13
diabetes (13) 13
electric countershock (13) 13
evidence review committee (13) 13
pacing (13) 13
percutaneous coronary intervention (13) 13
statins (13) 13
accessory atrioventricular bundle (12) 12
diagnosis (12) 12
echocardiography (12) 12
imaging (12) 12
intervention (12) 12
acc/aha practice guideline (11) 11
disease prevention (11) 11
health care (11) 11
measurement (11) 11
medical societies (11) 11
pacemaker (11) 11
physicians (11) 11
prognosis (11) 11
quality indicators (11) 11
quality of life (11) 11
societies, medical (11) 11
stroke (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the American College of Cardiology, ISSN 0735-1097, 03/2017, Volume 69, Issue 11, pp. 1465 - 1508
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2003, Volume 42, Issue 7, pp. 1318 - 1333
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 10/2018, Volume 72, Issue 14, pp. 1677 - 1749
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2018, Volume 71, Issue 19, pp. e127 - e248
Journal Article
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 07/2019, Volume 74, Issue 1, pp. 104 - 132
Indications for measurement of NOAC serum levels might include: ▪Measurement of drug levels in patients undergoing urgent surgical procedures. ▪Uncovering... 
ACC/AHA Clinical Practice Guidelines | coronary artery disease | antiplatelet agents | thromboembolism | atrial flutter | stents | myocardial infarction | idarucizumab | rivaroxaban | cardioversion | atrial fibrillation | percutaneous coronary intervention | acute coronary syndrome | anticoagulants | dabigatran | sleep apnea | obesity | anticoagulation agents | risk factors | apixaban | stroke | edoxaban | warfarin | focused update | coronary heart disease | hypertension | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Thromboembolism - etiology | Thromboembolism - prevention & control | Atrial Fibrillation - therapy | Humans | Atrial Fibrillation - complications | Heart | Therapy | Cardiac arrhythmia | Surgical implants | Science | Drug delivery | Sleep apnea | Risk factors | Body mass index | Fibrillation | Publishing | Bridging | Defibrillators | Education | Low molecular weights | Quality | Implants | Flutter | Cardiology | Presidents | Anticoagulants | Evaluation | Task forces | Stroke | Electronic equipment | Warfarin | Electronic devices | Level (quantity) | Advisors | Implantation | Management | Patients | Appendix | Heart valves | Serum levels | Scientific papers | Medicine | Weight control | Body mass | Pacemakers | Body size | Documents | Writing | Dialysis | Diagnostic systems | Internet | Clinical medicine | Heparin | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2019, Volume 73, Issue 24, pp. 3210 - 3227
Background: The 2013 American College of Cardiology/American Heart Association guidelines for the treatment of blood cholesterol found little evidence to support the use of nonstatin lipid-modifying medications... 
ACC/AHA Clinical Practice Guidelines | cardiovascular disease | patient compliance | risk assessment | lipids | drug therapy | risk reduction discussion | secondary prevention | hydroxymethylglutaryl-CoA reductase inhibitors/statins | biomarkers | ACC/AHA Evidence Review Committee | proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors | diabetes mellitus | hypercholesterolemia | pharmacological | Guidelines | LDL-cholesterol | coronary artery calcium score | ezetimibe | primary prevention | cholesterol | risk treatment discussion | Risk Assessment - methods | Hypercholesterolemia - blood | Risk Reduction Behavior | United States | Cardiovascular Diseases - prevention & control | Humans | Biomarkers - blood | Cardiology - standards | Medication Therapy Management - standards | Hypercholesterolemia - diagnosis | Anticholesteremic Agents - classification | Cardiovascular Diseases - psychology | Hypercholesterolemia - therapy | Anticholesteremic Agents - pharmacology | Cardiology - methods | Hypercholesterolemia - epidemiology | Prevention | Task forces | Hypercholesterolemia | Blood cholesterol | Low density lipoproteins | Anticholesteremic agents | Practice guidelines (Medicine) | Diabetes | Cardiology | Niacin | Patient compliance | Heart attack | Myocardial infarction | Therapy | Clinical trials | Lipids | Risk | Systematic review | Cognition | Blood | Proteins | Randomization | Vitamin B | Atherosclerosis | Proliferating cell nuclear antigen | Statins | Cerebral infarction | Stroke | Simvastatin | Triglycerides | Angina pectoris | Disease control | Cholesterol | Morbidity | Inhibitors | Arteriosclerosis | Health hazards | Writing | Clinical medicine | Cardiovascular diseases | Index Medicus | Abridged Index Medicus
Journal Article
by Levine, Glenn N., MD, FACC, FAHA and O’Gara, Patrick T., MD, FACC, FAHA and Bates, Eric R., MD, FACC, FAHA, FSCAI and Blankenship, James C., MD, FACC, FAHA, FSCAI and Kushner, Frederick G., MD, FACC, FAHA, FSCAI and Bailey, Steven R., MD, FACC, FSCAI and Bittl, John A., MD, FACC and Brindis, Ralph G., MD, MPH, MACC, FSCAI, FAHA and Casey, Donald E., MD, MPH, MBA, FAHA and Cercek, Bojan, MD, FACC, FAHA and Chambers, Charles E., MD, FACC, FSCAI and Chung, Mina K., MD, FACC, FAHA and de Lemos, James A., MD, FACC and Diercks, Deborah B., MD, MSc and Ellis, Stephen G., MD, FACC and Fang, James C., MD, FACC, FAHA and Franklin, Barry A., PhD, FAHA and Granger, Christopher B., MD, FACC, FAHA and Guyton, Robert A., MD, FACC and Hollenberg, Steven M., MD, FACC and Khot, Umesh N., MD, FACC and Krumholz, Harlan M., MD, SM, FACC, FAHA and Lange, Richard A., MD, FACC, FAHA and Linderbaum, Jane A., MS, CNP-BC and Mauri, Laura, MD, MSc, FACC, FSCAI and Mehran, Roxana, MD, FACC, FAHA, FSCAI and Morrow, David A., MD, MPH, FACC, FAHA and Moussa, Issam D., MD, FACC, FAHA, FSCAI and Mukherjee, Debabrata, MD, FACC, FAHA, FSCAI and Newby, L. Kristin, MD, MHS, FACC, FAHA and Ornato, Joseph P., MD, FACC, FAHA, FACP, FACEP and Ou, Narith, PharmD and Radford, Martha J., MD, FACC, FAHA and Tamis-Holland, Jacqueline E., MD, FACC, FSCAI and Ting, Henry H., MD, FACC, FAHA and Tommaso, Carl L., MD, FACC, FAHA, MSCAI and Tracy, Cynthia M., MD, FACC, FAHA and Woo, Y. Joseph, MD, FACC, FAHA and Zhao, David X., MD, FACC and Latin Amer Soc Interventional
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 67, Issue 10, pp. 1235 - 1250
Journal Article